Cetuximab (Erbitux)
Drug timelines are a Plus or Pro feature.
13 regulatory and trial events tracked for Cetuximab (Erbitux), covering 2010-09-23 to 2025-07-11. Get the full timeline:
Most recent: Clinical Trial Update: Short Course Radiotherapy Followed by CAPOX and Carrilizumab and Bevacizumab or Cetuximab for the Initial Treatment of Unresectable Metastatic Rectal Cancer [Phase 2]